Navigation Links
Halozyme Therapeutics To Present At The 32nd Annual J.P. Morgan Healthcare Conference
Date:1/9/2014

SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16, 2014 at 10:00 a.m. PT / 1:00 p.m. ET. Helen Torley, M.B. Ch. B., M.R.C.P., President and Chief Executive Officer of Halozyme Therapeutics, will provide a corporate overview.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com and follow us on Twitter @HALOTherapeutic.

Investor Contact:
Schond Greenway
Halozyme Therapeutics
858-704-8352
ir@halozyme.com

Media Contact:
Nurha Hindi
Hill + Knowlton Strategies
310-633-9434
Nurha.Hindi@hkstrategies.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
2. Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme
3. Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting
4. Halozyme to Host Fourth Quarter and 2012 Year-End Financial Results Conference Call
5. Halozyme to Host Second Quarter Financial Results Conference Call
6. Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March
7. Halozyme to Host Fourth Quarter and 2011 Year-End Financial Results Conference Call
8. Halozyme Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference
9. Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
10. Spark Therapeutics Expands Leadership Team to Support Development and Commercialization of its Late-Stage Gene Therapy Pipeline
11. Adheron Therapeutics Announces Favorable Phase 1 Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... Muncie, IN (PRWEB) , ... July 17, 2017 , ... ... 2017. The local celebration of National Model Aviation Day will take place from 9 ... is free and will include activities for all ages. , Aviation Adventure Day will ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... analytical instruments announced the launch of its new line of Heavy-Duty Orbital Shakers ... models (both analog and digital) for laboratory applications. These shakers are ideal ...
(Date:7/17/2017)... ... July 17, 2017 , ... Panitch Schwarze ... participated in the BiG (Biomedical Innovation Group) annual meeting in China. , This ... (chimeric antigen receptor T-cell) therapy, a rapidly developing highly personalized anti-cancer technology that ...
(Date:7/17/2017)... ... 2017 , ... DuPont Pioneer today announced the launch of ... dedicated to connecting third-party innovators with DuPont Pioneer scientists is now available and ... and digital solutions. , “DuPont Pioneer is building on its long history of ...
Breaking Biology Technology:
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed ... received the prestigious international IAIR Award for the most innovative high security ... ... Maldives Immigration Controller General, ... picture on the right) have received the IAIR award for the "Most ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
Breaking Biology News(10 mins):